25 XP   0   0   10

Kezar Life Sciences Inc
Buy, Hold or Sell?

Let's analyse Kezar Life Sciences Inc together

PenkeI guess you are interested in Kezar Life Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Kezar Life Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Kezar Life Sciences Inc

I send you an email if I find something interesting about Kezar Life Sciences Inc.

Quick analysis of Kezar Life Sciences Inc (30 sec.)










What can you expect buying and holding a share of Kezar Life Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.58
Expected worth in 1 year
$-1.95
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$-4.52
Return On Investment
-539.7%

For what price can you sell your share?

Current Price per Share
$0.84
Expected price per share
$0.7001 - $1.1
How sure are you?
50%

1. Valuation of Kezar Life Sciences Inc (5 min.)




Live pricePrice per Share (EOD)

$0.84

Intrinsic Value Per Share

$-14.13 - $-13.54

Total Value Per Share

$-11.55 - $-10.96

2. Growth of Kezar Life Sciences Inc (5 min.)




Is Kezar Life Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$187.5m$269.8m-$82.3m-43.9%

How much money is Kezar Life Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$101.8m-$65.3m-$36.5m-35.9%
Net Profit Margin-1,455.3%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Kezar Life Sciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#264 / 1007

Most Revenue
#453 / 1007

Most Profit
#745 / 1007

Most Efficient
#553 / 1007

What can you expect buying and holding a share of Kezar Life Sciences Inc? (5 min.)

Welcome investor! Kezar Life Sciences Inc's management wants to use your money to grow the business. In return you get a share of Kezar Life Sciences Inc.

What can you expect buying and holding a share of Kezar Life Sciences Inc?

First you should know what it really means to hold a share of Kezar Life Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Kezar Life Sciences Inc is $0.8378. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Kezar Life Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Kezar Life Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.58. Based on the TTM, the Book Value Change Per Share is $-1.13 per quarter. Based on the YOY, the Book Value Change Per Share is $1.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Kezar Life Sciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.40-167.0%-1.40-167.0%-0.94-111.9%-0.83-98.9%-0.59-70.1%
Usd Book Value Change Per Share-1.13-134.9%-1.13-134.9%1.00119.7%0.2225.8%0.3238.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.13-134.9%-1.13-134.9%1.00119.7%0.2225.8%0.3238.4%
Usd Price Per Share0.95-0.95-7.04-6.79-7.19-
Price to Earnings Ratio-0.68--0.68--7.51--9.58--15.26-
Price-to-Total Gains Ratio-0.84--0.84-7.02-4.90-6.21-
Price to Book Ratio0.37-0.37-1.90-2.98-3.83-
Price-to-Total Gains Ratio-0.84--0.84-7.02-4.90-6.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.8378
Number of shares1193
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.130.22
Usd Total Gains Per Share-1.130.22
Gains per Quarter (1193 shares)-1,348.69258.17
Gains per Year (1193 shares)-5,394.751,032.69
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-5395-5405010331023
20-10789-10800020652056
30-16184-16195030983089
40-21579-21590041314122
50-26974-26985051635155
60-32368-32380061966188
70-37763-37775072297221
80-43158-43170082618254
90-48553-48565092949287
100-53947-5396001032710320

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.08.00.00.0%0.08.00.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%4.04.00.050.0%4.04.00.050.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%4.04.00.050.0%4.04.00.050.0%

Fundamentals of Kezar Life Sciences Inc

About Kezar Life Sciences Inc

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor that is in Phase 2b clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; Phase 1b clinical trials in systemic lupus erythematosus; and completed Phase 2a clinical trials in lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Fundamental data was last updated by Penke on 2024-04-11 12:58:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Kezar Life Sciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Kezar Life Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Kezar Life Sciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -1,455.3% means that $-14.55 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Kezar Life Sciences Inc:

  • The MRQ is -1,455.3%. The company is making a huge loss. -2
  • The TTM is -1,455.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,455.3%TTM-1,455.3%0.0%
TTM-1,455.3%YOY--1,455.3%
TTM-1,455.3%5Y-291.1%-1,164.2%
5Y-291.1%10Y-181.9%-109.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,455.3%-207.2%-1,248.1%
TTM-1,455.3%-216.8%-1,238.5%
YOY--282.4%+282.4%
5Y-291.1%-434.0%+142.9%
10Y-181.9%-584.8%+402.9%
1.1.2. Return on Assets

Shows how efficient Kezar Life Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Kezar Life Sciences Inc to the Biotechnology industry mean.
  • -46.0% Return on Assets means that Kezar Life Sciences Inc generated $-0.46 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Kezar Life Sciences Inc:

  • The MRQ is -46.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -46.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-46.0%TTM-46.0%0.0%
TTM-46.0%YOY-21.8%-24.2%
TTM-46.0%5Y-30.6%-15.4%
5Y-30.6%10Y-33.5%+2.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-46.0%-13.2%-32.8%
TTM-46.0%-12.7%-33.3%
YOY-21.8%-11.5%-10.3%
5Y-30.6%-13.8%-16.8%
10Y-33.5%-15.5%-18.0%
1.1.3. Return on Equity

Shows how efficient Kezar Life Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Kezar Life Sciences Inc to the Biotechnology industry mean.
  • -54.3% Return on Equity means Kezar Life Sciences Inc generated $-0.54 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Kezar Life Sciences Inc:

  • The MRQ is -54.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -54.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-54.3%TTM-54.3%0.0%
TTM-54.3%YOY-24.2%-30.1%
TTM-54.3%5Y-34.7%-19.6%
5Y-34.7%10Y-24.4%-10.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-54.3%-16.7%-37.6%
TTM-54.3%-15.9%-38.4%
YOY-24.2%-14.7%-9.5%
5Y-34.7%-19.2%-15.5%
10Y-24.4%-20.0%-4.4%

1.2. Operating Efficiency of Kezar Life Sciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Kezar Life Sciences Inc is operating .

  • Measures how much profit Kezar Life Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Kezar Life Sciences Inc to the Biotechnology industry mean.
  • An Operating Margin of -1,503.4% means the company generated $-15.03  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Kezar Life Sciences Inc:

  • The MRQ is -1,503.4%. The company is operating very inefficient. -2
  • The TTM is -1,503.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,503.4%TTM-1,503.4%0.0%
TTM-1,503.4%YOY--1,503.4%
TTM-1,503.4%5Y-300.7%-1,202.7%
5Y-300.7%10Y-187.9%-112.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,503.4%-298.0%-1,205.4%
TTM-1,503.4%-238.5%-1,264.9%
YOY--291.9%+291.9%
5Y-300.7%-485.6%+184.9%
10Y-187.9%-610.8%+422.9%
1.2.2. Operating Ratio

Measures how efficient Kezar Life Sciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 16.03 means that the operating costs are $16.03 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Kezar Life Sciences Inc:

  • The MRQ is 16.034. The company is inefficient in keeping operating costs low. -1
  • The TTM is 16.034. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ16.034TTM16.0340.000
TTM16.034YOY-+16.034
TTM16.0345Y3.207+12.827
5Y3.20710Y2.004+1.203
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16.0343.235+12.799
TTM16.0343.310+12.724
YOY-3.791-3.791
5Y3.2075.675-2.468
10Y2.0047.558-5.554

1.3. Liquidity of Kezar Life Sciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Kezar Life Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 11.66 means the company has $11.66 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Kezar Life Sciences Inc:

  • The MRQ is 11.663. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.663. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.663TTM11.6630.000
TTM11.663YOY25.982-14.319
TTM11.6635Y19.883-8.220
5Y19.88310Y22.961-3.078
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.6633.877+7.786
TTM11.6634.178+7.485
YOY25.9825.343+20.639
5Y19.8836.135+13.748
10Y22.9616.468+16.493
1.3.2. Quick Ratio

Measures if Kezar Life Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Kezar Life Sciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 20.83 means the company can pay off $20.83 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Kezar Life Sciences Inc:

  • The MRQ is 20.826. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 20.826. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ20.826TTM20.8260.000
TTM20.826YOY46.619-25.792
TTM20.8265Y34.928-14.102
5Y34.92810Y35.257-0.329
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.8263.514+17.312
TTM20.8263.998+16.828
YOY46.6195.380+41.239
5Y34.9286.135+28.793
10Y35.2576.434+28.823

1.4. Solvency of Kezar Life Sciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Kezar Life Sciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Kezar Life Sciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.15 means that Kezar Life Sciences Inc assets are financed with 15.2% credit (debt) and the remaining percentage (100% - 15.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Kezar Life Sciences Inc:

  • The MRQ is 0.152. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.152. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.152TTM0.1520.000
TTM0.152YOY0.099+0.053
TTM0.1525Y0.110+0.043
5Y0.11010Y0.575-0.465
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1520.339-0.187
TTM0.1520.336-0.184
YOY0.0990.271-0.172
5Y0.1100.368-0.258
10Y0.5750.388+0.187
1.4.2. Debt to Equity Ratio

Measures if Kezar Life Sciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Kezar Life Sciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 17.9% means that company has $0.18 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Kezar Life Sciences Inc:

  • The MRQ is 0.179. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.179. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.179TTM0.1790.000
TTM0.179YOY0.110+0.069
TTM0.1795Y0.124+0.055
5Y0.12410Y0.084+0.040
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1790.388-0.209
TTM0.1790.403-0.224
YOY0.1100.340-0.230
5Y0.1240.430-0.306
10Y0.0840.463-0.379

2. Market Valuation of Kezar Life Sciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Kezar Life Sciences Inc generates.

  • Above 15 is considered overpriced but always compare Kezar Life Sciences Inc to the Biotechnology industry mean.
  • A PE ratio of -0.68 means the investor is paying $-0.68 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Kezar Life Sciences Inc:

  • The EOD is -0.599. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.677. Based on the earnings, the company is expensive. -2
  • The TTM is -0.677. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.599MRQ-0.677+0.078
MRQ-0.677TTM-0.6770.000
TTM-0.677YOY-7.511+6.834
TTM-0.6775Y-9.579+8.902
5Y-9.57910Y-15.257+5.678
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.599-2.281+1.682
MRQ-0.677-2.599+1.922
TTM-0.677-2.674+1.997
YOY-7.511-4.133-3.378
5Y-9.579-6.258-3.321
10Y-15.257-6.270-8.987
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Kezar Life Sciences Inc:

  • The EOD is -0.731. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.826. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.826. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.731MRQ-0.826+0.096
MRQ-0.826TTM-0.8260.000
TTM-0.826YOY-8.482+7.656
TTM-0.8265Y-11.518+10.691
5Y-11.51810Y-17.000+5.482
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.731-2.903+2.172
MRQ-0.826-3.323+2.497
TTM-0.826-3.552+2.726
YOY-8.482-5.592-2.890
5Y-11.518-8.378-3.140
10Y-17.000-8.875-8.125
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Kezar Life Sciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.37 means the investor is paying $0.37 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Kezar Life Sciences Inc:

  • The EOD is 0.325. Based on the equity, the company is cheap. +2
  • The MRQ is 0.368. Based on the equity, the company is cheap. +2
  • The TTM is 0.368. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.325MRQ0.368-0.043
MRQ0.368TTM0.3680.000
TTM0.368YOY1.899-1.531
TTM0.3685Y2.977-2.609
5Y2.97710Y3.835-0.858
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.3251.911-1.586
MRQ0.3682.116-1.748
TTM0.3682.097-1.729
YOY1.8992.885-0.986
5Y2.9773.556-0.579
10Y3.8353.959-0.124
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Kezar Life Sciences Inc.

3.1. Institutions holding Kezar Life Sciences Inc

Institutions are holding 67.977% of the shares of Kezar Life Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Suvretta Capital Management, LLC9.84540.307716759100
2023-12-31Avidity Partners Management LP6.9030.17355025454-985646-16.3971
2023-12-31BlackRock Inc6.6170.00014817266-135024-2.7265
2023-12-31Prosight Management, LP4.62261.283365333-1405466-29.4598
2023-12-31Vanguard Group Inc4.2080.00013063484229170.7537
2023-12-31Millennium Management LLC4.02130.00122927563-474550-13.9487
2023-12-31Sphera Funds Management Ltd.2.81820.3128205167600
2023-12-31Orbimed Advisors, LLC2.64690.03651927000-3536000-64.7263
2023-12-31Granahan Investment Management Inc..2.61830.0597190617545361731.2288
2023-12-31Geode Capital Management, LLC1.86070.00011354648620314.7989
2023-12-31Two Sigma Advisers, LLC1.81630.0029132230065240097.3877
2023-12-31Renaissance Technologies Corp1.77460.00191291919683223112.2437
2023-12-31Acadian Asset Management LLC1.72610.0046125663542494251.0936
2023-12-31Two Sigma Investments LLC1.67060.0027121624753780979.2717
2023-12-31State Street Corporation1.5330.0001111605234920.3139
2023-12-31Goldman Sachs Group Inc1.21620.0001885442-499564-36.0694
2023-12-31Ikarian Capital, LLC1.17220.075785339100
2023-12-31Qiming U.S. Ventures Management, LLC1.13830.718982871100
2023-09-30International Biotechnology Trust PLC0.96680.27987038257038250
2023-12-31Anson Funds Management LP0.83960.07166112496112490
Total 60.01513.329343691961-2880745-6.6%

3.2. Funds holding Kezar Life Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Biotech Growth Ord2.64690.436192700000
2024-02-29Vanguard Total Stock Mkt Idx Inv2.5790.0001187755500
2024-03-28iShares Russell 2000 ETF2.37280.002417274378340.0483
2023-12-31M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc1.08970.172479331000
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.05040.000876473000
2024-01-31Fidelity Small Cap Index0.95630.0028696199186342.7501
2024-03-28iShares Russell 2000 Value ETF0.90660.0048660045-419-0.0634
2023-12-31Victory Small Cap Stock0.59230.040743120213078043.5321
2023-12-31Granahan Inv Mgt Sm-Cap Core Gr0.59230.171143120213078043.5321
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.57340.001141745300
2024-01-31International Biotechnology Ord0.48130.104135039400
2024-02-29Fidelity Extended Market Index0.41920.0008305189-1479-0.4823
2024-02-29Vanguard Russell 2000 ETF0.35190.0028256223202928.6008
2024-01-31TIAA-CREF Equity Index Instl0.26830.000519531800
2023-12-31NT R2000 Value Index Fund - NL0.25930.0047188803-29412-13.4785
2023-12-31NT R2000 Index Fund - NL0.25750.0025187465-28920-13.3651
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.22450.001516342900
2024-02-29Schwab Small Cap Index0.22410.002916313200
2024-03-28iShares Micro-Cap ETF0.20860.014915186200
2023-12-31NT R2000 Index Fund - DC - NL - 20.20280.0025147630-23432-13.698
Total 16.25720.969411835578+217658+1.8%

3.3. Insider Transactions

Insiders are holding 14.807% of the shares of Kezar Life Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-02-06Morningside Venture InvestmentSELL400006.88
2023-02-03Morningside Venture InvestmentSELL250007.15
2023-01-30Morningside Venture InvestmentSELL300006.91
2023-01-25Morningside Venture InvestmentSELL500006.85
2023-01-23Morningside Venture InvestmentSELL800006.81
2023-01-17Morningside Venture InvestmentSELL61146.79
2023-01-12Morningside Venture InvestmentSELL50006.77
2023-01-05Morningside Venture InvestmentSELL121626.97
2022-10-03Morningside Venture InvestmentSELL287008.78
2022-03-21Franklin M BergerBUY2000014.77
2022-03-18Franklin M BergerBUY6000016.74
2022-01-03Michael KauffmanSELL500016.45

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Kezar Life Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.131-1.1310%1.003-213%0.216-622%0.322-451%
Book Value Per Share--2.5762.5760%3.707-30%2.399+7%1.612+60%
Current Ratio--11.66311.6630%25.982-55%19.883-41%22.961-49%
Debt To Asset Ratio--0.1520.1520%0.099+54%0.110+39%0.575-74%
Debt To Equity Ratio--0.1790.1790%0.110+63%0.124+45%0.084+113%
Dividend Per Share----0%-0%-0%-0%
Eps---1.399-1.3990%-0.937-33%-0.828-41%-0.588-58%
Free Cash Flow Per Share---1.146-1.1460%-0.830-28%-0.699-39%-0.506-56%
Free Cash Flow To Equity Per Share---1.138-1.1380%0.926-223%0.238-577%0.299-480%
Gross Profit Margin--1.0101.0100%1.000+1%1.002+1%1.001+1%
Intrinsic Value_10Y_max---13.539--------
Intrinsic Value_10Y_min---14.127--------
Intrinsic Value_1Y_max---0.842--------
Intrinsic Value_1Y_min---1.006--------
Intrinsic Value_3Y_max---2.923--------
Intrinsic Value_3Y_min---3.396--------
Intrinsic Value_5Y_max---5.476--------
Intrinsic Value_5Y_min---6.175--------
Market Cap60993012.920-13%68972046.36068972046.3600%512521856.000-87%494138046.472-86%523600409.045-87%
Net Profit Margin---14.553-14.5530%--100%-2.911-80%-1.819-88%
Operating Margin---15.034-15.0340%--100%-3.007-80%-1.879-88%
Operating Ratio--16.03416.0340%-+100%3.207+400%2.004+700%
Pb Ratio0.325-13%0.3680.3680%1.899-81%2.977-88%3.835-90%
Pe Ratio-0.599+12%-0.677-0.6770%-7.511+1009%-9.579+1315%-15.257+2153%
Price Per Share0.838-13%0.9470.9470%7.040-87%6.787-86%7.192-87%
Price To Free Cash Flow Ratio-0.731+12%-0.826-0.8260%-8.482+926%-11.518+1294%-17.000+1957%
Price To Total Gains Ratio-0.741+12%-0.838-0.8380%7.021-112%4.901-117%6.213-113%
Quick Ratio--20.82620.8260%46.619-55%34.928-40%35.257-41%
Return On Assets---0.460-0.4600%-0.218-53%-0.306-33%-0.335-27%
Return On Equity---0.543-0.5430%-0.242-55%-0.347-36%-0.244-55%
Total Gains Per Share---1.131-1.1310%1.003-213%0.216-622%0.322-451%
Usd Book Value--187570000.000187570000.0000%269872000.000-30%174668400.000+7%117378000.000+60%
Usd Book Value Change Per Share---1.131-1.1310%1.003-213%0.216-622%0.322-451%
Usd Book Value Per Share--2.5762.5760%3.707-30%2.399+7%1.612+60%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.399-1.3990%-0.937-33%-0.828-41%-0.588-58%
Usd Free Cash Flow---83455000.000-83455000.0000%-60424000.000-28%-50851800.000-39%-36820125.000-56%
Usd Free Cash Flow Per Share---1.146-1.1460%-0.830-28%-0.699-39%-0.506-56%
Usd Free Cash Flow To Equity Per Share---1.138-1.1380%0.926-223%0.238-577%0.299-480%
Usd Market Cap60993012.920-13%68972046.36068972046.3600%512521856.000-87%494138046.472-86%523600409.045-87%
Usd Price Per Share0.838-13%0.9470.9470%7.040-87%6.787-86%7.192-87%
Usd Profit---101870000.000-101870000.0000%-65316000.000-36%-58197200.000-43%-41457500.000-59%
Usd Revenue--7000000.0007000000.0000%-+100%1400000.000+400%875000.000+700%
Usd Total Gains Per Share---1.131-1.1310%1.003-213%0.216-622%0.322-451%
 EOD+3 -5MRQTTM+0 -0YOY+4 -305Y+7 -2710Y+8 -26

4.2. Fundamental Score

Let's check the fundamental score of Kezar Life Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.599
Price to Book Ratio (EOD)Between0-10.325
Net Profit Margin (MRQ)Greater than0-14.553
Operating Margin (MRQ)Greater than0-15.034
Quick Ratio (MRQ)Greater than120.826
Current Ratio (MRQ)Greater than111.663
Debt to Asset Ratio (MRQ)Less than10.152
Debt to Equity Ratio (MRQ)Less than10.179
Return on Equity (MRQ)Greater than0.15-0.543
Return on Assets (MRQ)Greater than0.05-0.460
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Kezar Life Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.815
Ma 20Greater thanMa 500.818
Ma 50Greater thanMa 1000.885
Ma 100Greater thanMa 2000.885
OpenGreater thanClose0.820
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Gross Profit  -1,301-243-1,54434-1,510487-1,0236,9575,934



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets221,235
Total Liabilities33,665
Total Stockholder Equity187,570
 As reported
Total Liabilities 33,665
Total Stockholder Equity+ 187,570
Total Assets = 221,235

Assets

Total Assets221,235
Total Current Assets206,950
Long-term Assets14,285
Total Current Assets
Cash And Cash Equivalents 35,493
Short-term Investments 165,879
Net Receivables 2,291
Other Current Assets 3,287
Total Current Assets  (as reported)206,950
Total Current Assets  (calculated)206,950
+/-0
Long-term Assets
Property Plant Equipment 8,690
Long-term Assets Other 5,595
Long-term Assets  (as reported)14,285
Long-term Assets  (calculated)14,285
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities17,744
Long-term Liabilities15,921
Total Stockholder Equity187,570
Total Current Liabilities
Short-term Debt 3,012
Accounts payable 8,251
Other Current Liabilities 6,481
Total Current Liabilities  (as reported)17,744
Total Current Liabilities  (calculated)17,744
+/- 0
Long-term Liabilities
Long term Debt 10,069
Capital Lease Obligations Min Short Term Debt5,852
Long-term Liabilities  (as reported)15,921
Long-term Liabilities  (calculated)15,921
+/-0
Total Stockholder Equity
Common Stock73
Retained Earnings -350,763
Accumulated Other Comprehensive Income -130
Other Stockholders Equity 538,390
Total Stockholder Equity (as reported)187,570
Total Stockholder Equity (calculated)187,570
+/-0
Other
Capital Stock73
Cash and Short Term Investments 201,372
Common Stock Shares Outstanding 72,554
Current Deferred Revenue0
Liabilities and Stockholders Equity 221,235
Net Debt -16,560
Net Invested Capital 197,639
Net Working Capital 189,206
Property Plant and Equipment Gross 14,110
Short Long Term Debt Total 18,933



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
11,424
54,222
114,682
89,513
151,842
217,933
299,568
221,235
221,235299,568217,933151,84289,513114,68254,22211,424
   > Total Current Assets 
10,487
52,326
109,805
81,132
144,811
211,654
285,722
206,950
206,950285,722211,654144,81181,132109,80552,32610,487
       Cash And Cash Equivalents 
9,747
51,033
24,182
14,951
21,228
62,882
40,456
35,493
35,49340,45662,88221,22814,95124,18251,0339,747
       Short-term Investments 
0
0
83,250
63,255
119,219
145,473
236,105
165,879
165,879236,105145,473119,21963,25583,25000
       Net Receivables 
377
498
5
642
766
70
0
2,291
2,2910707666425498377
       Other Current Assets 
598
508
489
1,048
1,631
729
920
3,287
3,2879207291,6311,048489508598
   > Long-term Assets 
937
1,896
4,877
8,381
7,031
6,279
13,846
14,285
14,28513,8466,2797,0318,3814,8771,896937
       Property Plant Equipment 
862
1,540
4,595
8,099
6,749
5,997
13,172
8,690
8,69013,1725,9976,7498,0994,5951,540862
       Other Assets 
75
356
282
282
282
282
674
0
067428228228228235675
> Total Liabilities 
28,852
79,909
5,885
11,467
10,864
21,057
29,696
33,665
33,66529,69621,05710,86411,4675,88579,90928,852
   > Total Current Liabilities 
651
1,484
3,337
6,003
6,442
8,212
10,997
17,744
17,74410,9978,2126,4426,0033,3371,484651
       Short-term Debt 
0
0
0
900
1,042
1,199
2,565
3,012
3,0122,5651,1991,042900000
       Accounts payable 
466
547
193
823
2,358
2,028
2,479
8,251
8,2512,4792,0282,358823193547466
       Other Current Liabilities 
185
937
3,144
62
21
4,985
5,953
6,481
6,4815,9534,98521623,144937185
   > Long-term Liabilities 
28,201
78,425
2,548
5,464
4,422
12,845
18,699
15,921
15,92118,69912,8454,4225,4642,54878,42528,201
       Long term Debt Total 
0
0
0
0
0
9,622
9,834
0
09,8349,62200000
       Long term Debt 
0
0
0
0
0
9,622
9,834
10,069
10,0699,8349,62200000
       Capital Lease Obligations Min Short Term Debt
0
0
0
5,464
4,422
3,223
8,865
5,852
5,8528,8653,2234,4225,464000
       Other Liabilities 
25
494
2,548
0
0
0
0
0
000002,54849425
       Long-term Liabilities Other 
25
494
0
5,464
4,422
3,223
8,865
0
08,8653,2234,4225,464049425
       Deferred Long Term Liability 
0
0
2,548
0
0
0
0
0
000002,54800
> Total Stockholder Equity
-17,428
-25,687
108,797
78,046
140,978
196,876
269,872
187,570
187,570269,872196,876140,97878,046108,797-25,687-17,428
   Common Stock
1
1
19
19
46
56
68
73
73685646191911
   Retained Earnings -350,763-248,893-180,654-126,024-84,282-49,195-26,028-17,511
   Accumulated Other Comprehensive Income -130-923-291-137-196-203-111-150
   Capital Surplus 
232
451
158,176
162,505
267,093
377,765
519,620
0
0519,620377,765267,093162,505158,176451232
   Treasury Stock00000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue7,000
Cost of Revenue-1,066
Gross Profit5,9345,934
 
Operating Income (+$)
Gross Profit5,934
Operating Expense-111,171
Operating Income-105,237-105,237
 
Operating Expense (+$)
Research Development85,697
Selling General Administrative26,540
Selling And Marketing Expenses1,066
Operating Expense111,171113,303
 
Net Interest Income (+$)
Interest Income10,578
Interest Expense-1,550
Other Finance Cost-50
Net Interest Income9,078
 
Pretax Income (+$)
Operating Income-105,237
Net Interest Income9,078
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-101,870-108,604
EBIT - interestExpense = -106,787
-101,870
-100,320
Interest Expense1,550
Earnings Before Interest and Taxes (EBIT)-105,237-100,320
Earnings Before Interest and Taxes (EBITDA)-104,171
 
After tax Income (+$)
Income Before Tax-101,870
Tax Provision-0
Net Income From Continuing Ops-87,791-101,870
Net Income-101,870
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses112,237
Total Other Income/Expenses Net3,367-9,078
 

Technical Analysis of Kezar Life Sciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Kezar Life Sciences Inc. The general trend of Kezar Life Sciences Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Kezar Life Sciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Kezar Life Sciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.88 < 1.04 < 1.1.

The bearish price targets are: 0.7701 > 0.7502 > 0.7001.

Tweet this
Kezar Life Sciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Kezar Life Sciences Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Kezar Life Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Kezar Life Sciences Inc. The current macd is -0.0209648.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Kezar Life Sciences Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Kezar Life Sciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Kezar Life Sciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Kezar Life Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartKezar Life Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Kezar Life Sciences Inc. The current adx is 17.55.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Kezar Life Sciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Kezar Life Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Kezar Life Sciences Inc. The current sar is 0.89862516.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Kezar Life Sciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Kezar Life Sciences Inc. The current rsi is 49.81. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Kezar Life Sciences Inc Daily Relative Strength Index (RSI) ChartKezar Life Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Kezar Life Sciences Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Kezar Life Sciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Kezar Life Sciences Inc Daily Stochastic Oscillator ChartKezar Life Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Kezar Life Sciences Inc. The current cci is 44.82.

Kezar Life Sciences Inc Daily Commodity Channel Index (CCI) ChartKezar Life Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Kezar Life Sciences Inc. The current cmo is 7.68197564.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Kezar Life Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartKezar Life Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Kezar Life Sciences Inc. The current willr is -38.39854413.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Kezar Life Sciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Kezar Life Sciences Inc Daily Williams %R ChartKezar Life Sciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Kezar Life Sciences Inc.

Kezar Life Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Kezar Life Sciences Inc. The current atr is 0.0509609.

Kezar Life Sciences Inc Daily Average True Range (ATR) ChartKezar Life Sciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Kezar Life Sciences Inc. The current obv is 198,218.

Kezar Life Sciences Inc Daily On-Balance Volume (OBV) ChartKezar Life Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Kezar Life Sciences Inc. The current mfi is 56.65.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Kezar Life Sciences Inc Daily Money Flow Index (MFI) ChartKezar Life Sciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Kezar Life Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Kezar Life Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Kezar Life Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.815
Ma 20Greater thanMa 500.818
Ma 50Greater thanMa 1000.885
Ma 100Greater thanMa 2000.885
OpenGreater thanClose0.820
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Kezar Life Sciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Kezar Life Sciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Kezar Life Sciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Kezar Life Sciences Inc

I send you an email if I find something interesting about Kezar Life Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Kezar Life Sciences Inc.

Receive notifications about Kezar Life Sciences Inc in your mailbox!